Guillain-Barré syndrome incidence in a large United States cohort (2000-2009).

scientific article

Guillain-Barré syndrome incidence in a large United States cohort (2000-2009). is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1159/000339248
P698PubMed publication ID22846726

P50authorEric S WeintraubQ105288956
Grace M LeeQ105289067
P2093author name stringAnthony A Amato
W Katherine Yih
Irene M Shui
Sarah I Sheikh
Melisa D Rett
Michael Marcy
Doreen Ho
Vaccine Safety Datalink Research Team
P2860cites workGuillain-Barré syndrome and influenza virus infectionQ34885906
Vaccines and Guillain-Barré syndromeQ34977408
The epidemiology of Guillain-Barré syndrome worldwide. A systematic literature reviewQ37352531
Rates of autoimmune diseases in Kaiser Permanente for use in vaccine adverse event safety studiesQ37629055
Guillain-Barré syndrome and influenza vaccination in the US Army, 1980-1988.Q41890248
Hospital Discharge Data for Guillain-Barré Syndrome and Influenza A (H1N1) Vaccine Adverse EventsQ42598383
Guillain-Barré syndrome in Greece: seasonality and other clinico-epidemiological featuresQ43598553
Mild forms of Guillain-Barré syndrome in an epidemiologic survey in The NetherlandsQ45056542
An assessment of the safety of adolescent and adult tetanus-diphtheria-acellular pertussis (Tdap) vaccine, using active surveillance for adverse events in the Vaccine Safety DatalinkQ45245349
The Guillain-Barré syndrome and the 1992-1993 and 1993-1994 influenza vaccines.Q50852734
No Association Between Immunization and Guillain-Barré Syndrome in the United Kingdom, 1992 to 2000Q57388524
Guillain-Barré Syndrome After Influenza Vaccination in AdultsQ57661024
Guillain–Barré syndrome and Fisher syndrome: Case definitions and guidelines for collection, analysis, and presentation of immunization safety dataQ22251433
Guillain-Barré syndromeQ24276200
Measles-mumps-rubella-varicella combination vaccine and the risk of febrile seizuresQ28286437
Investigation of the temporal association of Guillain-Barre syndrome with influenza vaccine and influenzalike illness using the United Kingdom General Practice Research Database.Q30373486
Importance of background rates of disease in assessment of vaccine safety during mass immunisation with pandemic H1N1 influenza vaccinesQ30382146
Near real-time surveillance for influenza vaccine safety: proof-of-concept in the Vaccine Safety Datalink Project.Q30383245
The use of hospital discharge data for public health surveillance of guillain-barré syndromeQ31131132
Validity of hospital discharge diagnoses for public health surveillance of the Guillain-Barrè syndromeQ33184930
Guillain-Barré syndrome and preceding infection with campylobacter, influenza and Epstein-Barr virus in the general practice research database.Q33280997
Why delaying levodopa is a good treatment strategy in early Parkinson's diseaseQ34071711
The Vaccine Safety Datalink projectQ34110382
Guillain-Barré syndrome in the United States, 1979-1980 and 1980-1981. Lack of an association with influenza vaccinationQ34278694
Guillain-Barré syndrome: incidence and mortality rates in US hospitalsQ34591194
P433issue2
P921main subjectUnited States of AmericaQ30
Guillain–Barré syndromeQ205214
P304page(s)109-115
P577publication date2012-07-28
P1433published inNeuroepidemiologyQ15764043
P1476titleGuillain-Barré syndrome incidence in a large United States cohort (2000-2009).
P478volume39

Reverse relations

cites work (P2860)
Q37330060Clinical Heterogeneity of Guillain-Barré Syndrome in the Emergency Department: Impact on Clinical Outcome.
Q41548361Clinical and epidemiological features of Guillain-Barré syndrome in the Western Balkans.
Q51849672Cumulative risk of Guillain-Barré syndrome among vaccinated and unvaccinated populations during the 2009 H1N1 influenza pandemic.
Q33165769Deaths following vaccination: What does the evidence show?
Q47228240Epidemiology of Guillain-Barré syndrome in Finland 2004-2014.
Q66680672Estimation of the Incidence of Guillain-Barré Syndrome During Pregnancy in the United States
Q50536179Factors contributing to delay in diagnosis of Guillain-Barré syndrome and impact on clinical outcome.
Q39639984Guillain-Barré Syndrome and Human Immunodeficiency Virus.
Q30351998Guillain-Barré Syndrome, Influenza Vaccination, and Antecedent Respiratory and Gastrointestinal Infections: A Case-Centered Analysis in the Vaccine Safety Datalink, 2009-2011.
Q30374886Guillain-Barré syndrome and influenza vaccines: A meta-analysis.
Q92978114Guillain-Barré syndrome and influenza vaccines: current evidence
Q63727422Guillain-Barré syndrome in Denmark: validation of diagnostic codes and a population-based nationwide study of the incidence in a 30-year period
Q31149945Guillain-Barré syndrome in France: a nationwide epidemiological analysis based on hospital discharge data (2008-2013).
Q40770321Impact of the birth's season on the development of celiac disease in Italy
Q39540115Incidence of Guillain-Barré syndrome in Chile: a population-based study
Q30431960International collaboration to assess the risk of Guillain Barré Syndrome following Influenza A (H1N1) 2009 monovalent vaccines
Q30372280Pandemic influenza A vaccination and incidence of Guillain-Barré syndrome in Korea.
Q41273106Relationship between Guillain-Barré syndrome, influenza-related hospitalizations, and influenza vaccine coverage
Q41995480Risk of Guillain-Barré Syndrome following quadrivalent human papillomavirus vaccine in the Vaccine Safety Datalink.
Q33410901Seasonal distribution of severe ADAMTS13 deficient idiopathic thrombotic thrombocytopenic purpura
Q38633484Transplanted human fecal microbiota enhanced Guillain Barré syndrome autoantibody responses after Campylobacter jejuni infection in C57BL/6 mice.
Q42361533Vaccination and autoimmune diseases: is prevention of adverse health effects on the horizon?
Q59395283Vaccine-preventable diseases, vaccines and Guillain-Barre’ syndrome

Search more.